Atypical Bacteria

• Definition: "Atypical" bacteria are pathogens that cause clinical syndromes indistinguishable from — or overlapping with — typical pyogenic infection, yet are invisible on Gram stain, unculturable on routine media, and intrinsically unresponsive to cell-wall–active drugs. The term is a clinical-microbiologic convenience, not a taxonomic one.
• Why it matters: They drive a substantial share of community-acquired pneumonia (CAP) and virtually all non-gonococcal urethritis/cervicitis. Because routine sputum and blood cultures are sterile, a beta-lactam–only regimen fails silently; the 2019 ATS/IDSA CAP guideline therefore builds atypical coverage (macrolide, doxycycline, or respiratory fluoroquinolone) into most empiric regimens.

Epidemiology worth recalling

• Mycoplasma pneumoniae: leading cause of atypical CAP in school-age children, adolescents, and young adults; spreads by respiratory droplets in closed settings (dormitories, military barracks, households) with periodic multi-year epidemic waves. Illness is usually mild enough that patients remain ambulatory — walking pneumonia.
• Legionella pneumophila: disease of older adults, smokers, chronic lung disease, and cell-mediated immune suppression (glucocorticoids, TNF-alpha inhibitors, transplant). Acquired by inhaling aerosols from cooling towers, hot tubs, decorative fountains, and building water systems; no person-to-person transmission, so clusters point to a common water source and are reportable to public health.
• Chlamydia trachomatis: per CDC surveillance, the most frequently reported notifiable bacterial infection in the United States, concentrated in sexually active persons under 25; the majority of infections in women are asymptomatic, which is the rationale for USPSTF-endorsed screening.
• Rickettsia rickettsii (Rocky Mountain spotted fever): tick-borne, peaks in spring and summer, and despite the name is reported most heavily from the southeastern and south-central states.
• Coxiella burnetii: occupational zoonosis of ranchers, veterinarians, and abattoir workers exposed to parturient livestock.

Cell-wall biology explains the Gram stain

• Mycoplasma pneumoniae: the smallest free-living bacterium; no peptidoglycan at all, with cholesterol (sterols) stabilizing the plasma membrane — a feature unique among bacteria and acquired from the host. Grows slowly on Eaton agar producing fried-egg colonies; culture takes weeks and is not used clinically. Mycoplasma hominis and Ureaplasma are genitourinary relatives.
• Chlamydiae (C. trachomatis, C. pneumoniae, C. psittaci): obligate intracellular organisms with a Gram-negative–type envelope but lacking classic muramic acid–containing peptidoglycan. Biphasic life cycle: the elementary body is small, metabolically inert, and infectious; the reticulate body is the replicative intracellular form that divides within a membrane-bound inclusion. Chlamydiae cannot make sufficient ATP and behave as energy parasites. Cytoplasmic inclusions stain with Giemsa or iodine; historical isolation used McCoy cell culture.
• Legionella pneumophila: a fastidious Gram-negative rod that stains poorly because of its branched-chain fatty acid–rich envelope; use silver stain on tissue. Requires buffered charcoal yeast extract (BCYE) agar supplemented with cysteine and iron — the classic exam growth requirement. Facultative (not obligate) intracellular.
• **Rickettsiae and *Coxiella burnetii***: obligate intracellular Gram-negative coccobacilli; poorly visualized by Gram stain, demonstrated by immunohistochemistry on skin biopsy. Coxiella forms a highly stable spore-like small-cell variant, permitting airborne spread from birth products and dust with a very low infectious dose.

Virulence factors tested

• P1 adhesin of M. pneumoniae binds sialylated receptors at the base of respiratory cilia; CARDS toxin contributes to epithelial injury.
• Dot/Icm type IV secretion system of Legionella injects effectors that block phagosome–lysosome fusion, allowing replication inside alveolar macrophages.
• Rickettsial actin-based motility and OmpA/OmpB adhesins mediate endothelial invasion and cell-to-cell spread.
• Phase I versus phase II lipopolysaccharide antigenic variation in Coxiella distinguishes chronic from acute infection serologically.

Respiratory atypicals — why the chest film outruns the exam

• Mycoplasma: P1 adhesin anchors the organism to the ciliated respiratory epithelium, causing ciliostasis and epithelial sloughing without invasion of alveoli. Injury is largely peribronchial and interstitial, so the CXR shows diffuse reticulonodular or patchy interstitial infiltrates while auscultation and percussion are near-normal — the classic radiographic–clinical dissociation. Loss of mucociliary clearance produces a persistent hacking dry cough.
• Autoimmune sequelae: mycoplasmal membrane glycolipids resemble the erythrocyte I antigen, so cross-reactive IgM cold agglutinins arise and can produce cold autoimmune hemolytic anemia and Raynaud-like acrocyanosis. Similar molecular mimicry underlies erythema multiforme / mucositis, Guillain–Barré syndrome, and encephalitis.
• Legionella: inhaled aerosolized bacteria are phagocytosed by alveolar macrophages but subvert the phagosome via the Dot/Icm system, replicating intracellularly until the cell lyses. This provokes an intense neutrophilic, often necrotizing alveolar exudate — hence high fever, hypoxemia, and lobar or multifocal consolidation, a more severe picture than Mycoplasma. Because control requires cell-mediated immunity, defects in T-cell/macrophage function (steroids, TNF-alpha inhibitors) are the key risk. Systemic cytokine release plus renal tubular effects contribute to hyponatremia (frequently SIADH-pattern), transaminitis, diarrhea, and **relative bradycardia (Faget sign)**.

Intracellular and mucosal invaders

• Chlamydia trachomatis: repeated cycles of elementary-body infection and reticulate-body replication in columnar epithelium drive a chronic lymphoid inflammatory response. Persistent inflammation with fibrosis explains tubal scarring, ectopic pregnancy, and infertility in the genital tract and conjunctival scarring with entropion/trichiasis in trachoma. Heat-shock protein–driven immunopathology, not bacterial burden, causes much of the damage; HLA-B27–associated reactive arthritis follows the same immune cross-reactivity theme.
• Rickettsiae: tropism for vascular endothelium produces a small-vessel vasculitis. Endothelial injury causes capillary leak, consumptive thrombocytopenia, hyponatremia, petechial rash, and in severe cases noncardiogenic pulmonary edema, encephalitis, and shock — a systemic vascular disease masquerading as a febrile viral illness.

Pulmonary syndromes

• ***Mycoplasma* tracheobronchitis/pneumonia: gradual onset over days in an otherwise healthy adolescent or young adult — sore throat, headache, malaise, low-grade fever, then a protracted nonproductive cough. Look for *bullous myringitis*, cold agglutinin–mediated hemolysis**, and mucocutaneous eruptions ranging from erythema multiforme to Stevens–Johnson–like mucositis. Sickle cell disease predisposes to severe disease.
• Legionnaires disease: abrupt high fever, rigors, dyspnea, watery diarrhea, abdominal pain, confusion, and relative bradycardia in a smoker, older adult, or immunosuppressed host with recent hotel, cruise, hot tub, or hospital water exposure. Labs show hyponatremia, elevated transaminases, and sometimes elevated CK. Pontiac fever is the same organism producing a self-limited flu-like illness without pneumonia.
• Chlamydia pneumoniae: mild pneumonia or prolonged bronchitis in adolescents, often with hoarseness and biphasic illness.
• Chlamydia psittaci (psittacosis): high fever, severe headache, and dry cough after parrot/parakeet/poultry exposure; splenomegaly is a clue.
• Q fever: abrupt fever with granulomatous hepatitis or pneumonia after livestock/parturient-animal exposure; chronic disease presents years later as culture-negative endocarditis, classically on a prosthetic or previously abnormal valve.

Genitourinary and neonatal syndromes (C. trachomatis)

• Serovars D–K: urethritis, mucopurulent cervicitis, epididymitis, and pelvic inflammatory disease, with perihepatitis (Fitz-Hugh–Curtis syndrome) causing RUQ pain. Most infections in women are asymptomatic.
• Neonatal disease from vaginal delivery: conjunctivitis at 5–14 days (later than gonococcal) and, at roughly 1–3 months, an afebrile pneumonia with staccato cough, tachypnea, and eosinophilia.
• Serovars L1–L3 (LGV): painless genital ulcer followed by tender, suppurative inguinal buboes and the groove sign; proctocolitis in men who have sex with men.
• Serovars A–C: chronic trachoma, the leading infectious cause of blindness worldwide.

Vector-borne

• RMSF: fever, severe headache, myalgias, then a macular rash beginning on wrists and ankles spreading centripetally to include palms and soles; thrombocytopenia and hyponatremia are typical, and the rash may be absent early or entirely.

Frame the pneumonia first

• CXR establishes pneumonia; findings are typically out of proportion to exam in Mycoplasma and lobar/multilobar in Legionella. The 2019 ATS/IDSA CAP guideline recommends using a validated severity tool — Pneumonia Severity Index (PSI), preferred over CURB-65 — plus the IDSA/ATS severe CAP criteria (which include septic shock requiring vasopressors and respiratory failure requiring mechanical ventilation as major criteria) to decide site of care.
• Routine sputum Gram stain and blood cultures are recommended by that guideline mainly for severe CAP or when MRSA/*Pseudomonas* is a concern; in atypical infection they are characteristically negative or show neutrophils without organisms — a finding that should redirect, not reassure.

Organism-specific testing

• Legionella: urinary antigen is the initial test — rapid, unaffected by prior antibiotics, but detects only serogroup 1 and remains positive for weeks. Pair it with lower-respiratory culture on BCYE agar (the reference standard, and the only way to type isolates for outbreak investigation) or respiratory PCR. ATS/IDSA 2019 recommends urinary antigen and Legionella culture/NAAT in severe CAP and when epidemiologic factors (outbreak, recent travel) are present rather than routinely.
• ***Mycoplasma*/*Chlamydia pneumoniae*: nucleic acid amplification of a nasopharyngeal or throat swab, often as part of a multiplex respiratory panel, is the practical test. Serology requires paired acute and convalescent titers and is retrospective. Cold agglutinins** are insensitive and nonspecific — a bedside curiosity and exam buzzword, not a diagnostic standard.
• Chlamydia trachomatis: NAAT is the gold standard — first-catch urine or vaginal swab, with rectal/pharyngeal swabs at exposed sites; culture is obsolete. CDC recommends concurrent gonorrhea NAAT and a test of reinfection at about 3 months, not a test of cure (except in pregnancy).
• Rickettsia/Coxiella: indirect immunofluorescence antibody on paired sera is confirmatory but retrospective; skin-biopsy immunohistochemistry and whole-blood PCR can confirm acutely. Coxiella phase I IgG markedly elevated signals chronic Q fever. The Weil–Felix Proteus agglutination test is historical and unreliable.
• Critical principle (CDC 2016): never delay doxycycline for confirmatory serology in suspected RMSF.

Empiric CAP (ATS/IDSA 2019)

• Outpatient, no comorbidities: amoxicillin, doxycycline (tetracycline), or a macrolide (azithromycin) — the macrolide only where local pneumococcal macrolide resistance is low (guideline threshold under 25%).
• Outpatient with comorbidities: beta-lactam plus macrolide or doxycycline, or a respiratory fluoroquinolone (levofloxacin, moxifloxacin) as monotherapy.
• Inpatient: beta-lactam (ceftriaxone or ampicillin-sulbactam) plus a macrolide, or a respiratory fluoroquinolone. For severe CAP, the guideline favors beta-lactam plus macrolide, with beta-lactam plus fluoroquinolone as the alternative. The rationale is precisely that atypicals are not covered by the beta-lactam component.

Directed therapy

• Legionella: levofloxacin or azithromycin; treat longer in immunocompromised or severe disease. Pontiac fever needs no antibiotics. Prevention is engineering-based — water-system temperature control, disinfection, and public-health outbreak investigation; there is no vaccine.
• Mycoplasma: macrolide or doxycycline; a respiratory fluoroquinolone is an alternative in adults. Macrolide resistance via 23S rRNA point mutation is well described (highest reported rates in East Asia) and should prompt a switch to doxycycline or a fluoroquinolone when a patient fails to defervesce.
• Chlamydia trachomatis: per the CDC 2021 STI Treatment Guidelines, doxycycline 100 mg PO twice daily for 7 days is now preferred for uncomplicated urogenital infection, with azithromycin 1 g single dose as an alternative; azithromycin 1 g is the recommended regimen in pregnancy since tetracyclines are avoided. LGV requires doxycycline for 21 days. PID regimens pair ceftriaxone with doxycycline plus metronidazole. Treat partners and screen per USPSTF (sexually active women 24 and younger, and older women at increased risk).
• Neonatal chlamydial conjunctivitis/pneumonia: oral erythromycin or azithromycin — topical therapy is inadequate, and erythromycin in infants carries a pyloric stenosis risk. Erythromycin eye ointment given at birth prevents gonococcal, not chlamydial, ophthalmia.
• RMSF and other rickettsioses: doxycycline for all ages, including children under 8 (CDC 2016; AAP Red Book) — the short course does not meaningfully stain teeth, and chloramphenicol is inferior. Chronic Q fever endocarditis requires doxycycline plus hydroxychloroquine for 18 months or longer.

• Cell-wall logic drives every answer: no peptidoglycan target means beta-lactams and vancomycin are useless. If a stem says "failed amoxicillin" or "failed ceftriaxone" in a young patient with pneumonia, the answer is a macrolide, doxycycline, or respiratory fluoroquinolone.
• "Grows only on charcoal yeast extract with cysteine and iron" is Legionella, full stop. Pair it with **hyponatremia, diarrhea, confusion, and relative bradycardia (Faget sign); the single best initial test is the urinary antigen, remembering it detects serogroup 1 only**.
• Cold agglutinins + bullous myringitis + walking pneumonia = Mycoplasma. The mechanism examiners want is IgM against the erythrocyte I antigen from molecular mimicry. Also link Mycoplasma to erythema multiforme and Guillain–Barré.
• Suspected Rocky Mountain spotted fever: the single best next step is empiric doxycycline now, before serology. Doxycycline is given even to children under 8. The rash starting on wrists and ankles and involving palms and soles distinguishes it from epidemic typhus, whose rash starts centrally and spares palms and soles.
• Neonatal eye discharge timing: day 1 chemical, days 2–5 gonococcal, days 5–14 chlamydial. Chlamydial disease needs systemic erythromycin or azithromycin — a classic distractor is topical ointment, which does not eradicate nasopharyngeal carriage and does not prevent later staccato-cough pneumonia with eosinophilia.
• Culture-negative endocarditis after farm-animal or parturient-livestock exposure is Q fever; note Coxiella is aerosol-transmitted with no arthropod vector in humans and has a spore-like stable form.
• The chlamydial life cycle shows up as a one-liner: elementary body = infectious and inert; reticulate body = replicating and non-infectious.
• Common trap: a negative routine sputum culture in atypical pneumonia is not evidence of viral illness — it is the expected result, and per ATS/IDSA 2019 the empiric regimen must already include atypical coverage.

• Gram-stain negative or poorly staining organisms that don't grow on standard media (MacConkey, blood agar)
• Major atypicals: Chlamydia, Mycoplasma, Legionella, Rickettsia, Coxiella
• Require special culture media, PCR, or serology for diagnosis
• Commonly cause respiratory infections, zoonotic diseases, and STIs
• Share characteristic of obligate intracellular parasites (except Mycoplasma)

• Missing atypical diagnosis: Standard sputum culture returns negative → assume viral or order appropriate serology/PCR rather than defaulting to S. pneumoniae therapy
• Beta-lactam monotherapy failure: Remembering atypicals are resistant to penicillins/cephalosporins; requires macrolides, tetracyclines, or fluoroquinolones
• Ignoring extrapulmonary manifestations: Reactive arthritis (Chlamydia), endocarditis (Coxiella), or sepsis (Legionella) may overshadow respiratory symptoms

• Chlamydia: Azithromycin (macrolide) or doxycycline (tetracycline)
• Mycoplasma: Macrolides (azithromycin) or doxycycline
• Legionella: Fluoroquinolone (levofloxacin) or macrolide
• Rickettsia: Doxycycline (early empiric use in endemic areas before confirmation)
• Coxiella: Doxycycline; prolonged treatment for chronic Q fever